PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIOX vs. FULC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


BIOXFULC
YTD Return-53.24%-50.81%
1Y Return-44.99%-20.57%
3Y Return (Ann)-24.70%-43.01%
5Y Return (Ann)2.13%-16.16%
Sharpe Ratio-1.25-0.17
Sortino Ratio-1.870.55
Omega Ratio0.761.09
Calmar Ratio-0.70-0.17
Martin Ratio-1.71-0.40
Ulcer Index24.37%38.62%
Daily Std Dev33.45%94.01%
Max Drawdown-60.06%-92.70%
Current Drawdown-59.88%-89.28%

Fundamentals


BIOXFULC
Market Cap$403.23M$227.14M
EPS$0.05-$0.34
Total Revenue (TTM)$472.93M$80.87M
Gross Profit (TTM)$186.84M$79.48M
EBITDA (TTM)$50.25M-$3.95M

Correlation

-0.50.00.51.00.1

The correlation between BIOX and FULC is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

BIOX vs. FULC - Performance Comparison

The year-to-date returns for both investments are quite close, with BIOX having a -53.24% return and FULC slightly higher at -50.81%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-44.22%
-57.41%
BIOX
FULC

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BIOX vs. FULC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bioceres Crop Solutions Corp. (BIOX) and Fulcrum Therapeutics, Inc. (FULC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIOX
Sharpe ratio
The chart of Sharpe ratio for BIOX, currently valued at -1.25, compared to the broader market-4.00-2.000.002.004.00-1.25
Sortino ratio
The chart of Sortino ratio for BIOX, currently valued at -1.87, compared to the broader market-4.00-2.000.002.004.006.00-1.87
Omega ratio
The chart of Omega ratio for BIOX, currently valued at 0.76, compared to the broader market0.501.001.502.000.76
Calmar ratio
The chart of Calmar ratio for BIOX, currently valued at -0.69, compared to the broader market0.002.004.006.00-0.70
Martin ratio
The chart of Martin ratio for BIOX, currently valued at -1.71, compared to the broader market0.0010.0020.0030.00-1.71
FULC
Sharpe ratio
The chart of Sharpe ratio for FULC, currently valued at -0.17, compared to the broader market-4.00-2.000.002.004.00-0.17
Sortino ratio
The chart of Sortino ratio for FULC, currently valued at 0.55, compared to the broader market-4.00-2.000.002.004.006.000.55
Omega ratio
The chart of Omega ratio for FULC, currently valued at 1.09, compared to the broader market0.501.001.502.001.09
Calmar ratio
The chart of Calmar ratio for FULC, currently valued at -0.17, compared to the broader market0.002.004.006.00-0.17
Martin ratio
The chart of Martin ratio for FULC, currently valued at -0.40, compared to the broader market0.0010.0020.0030.00-0.40

BIOX vs. FULC - Sharpe Ratio Comparison

The current BIOX Sharpe Ratio is -1.25, which is lower than the FULC Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of BIOX and FULC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00JuneJulyAugustSeptemberOctoberNovember
-1.25
-0.17
BIOX
FULC

Dividends

BIOX vs. FULC - Dividend Comparison

Neither BIOX nor FULC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BIOX vs. FULC - Drawdown Comparison

The maximum BIOX drawdown since its inception was -60.06%, smaller than the maximum FULC drawdown of -92.70%. Use the drawdown chart below to compare losses from any high point for BIOX and FULC. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%JuneJulyAugustSeptemberOctoberNovember
-59.88%
-89.28%
BIOX
FULC

Volatility

BIOX vs. FULC - Volatility Comparison

Bioceres Crop Solutions Corp. (BIOX) and Fulcrum Therapeutics, Inc. (FULC) have volatilities of 12.08% and 11.90%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%JuneJulyAugustSeptemberOctoberNovember
12.08%
11.90%
BIOX
FULC

Financials

BIOX vs. FULC - Financials Comparison

This section allows you to compare key financial metrics between Bioceres Crop Solutions Corp. and Fulcrum Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items